Literature DB >> 17641721

Early clinical experience with leflunomide in uveitis.

Mili Roy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641721     DOI: 10.3129/can j ophthalmol.i07-085

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  6 in total

1.  [Intermediate uveitis: guidelines of the German Ophthalmological Society and the Professional Association of German Ophthalmologists].

Authors:  F Mackensen; L Baydoun; J Garweg; A Heiligenhaus; T Hudde
Journal:  Ophthalmologe       Date:  2014-11       Impact factor: 1.059

2.  Flare up of rheumatoid arthritis associated with Vogt-Koyanagi-Harada syndrome treated with leflunomide.

Authors:  Jia Wang; Qi-Bing Xie; Yi Zhao; Yi Liu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

Review 3.  [Guidelines nr. 24a intermediate uveitis].

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

4.  [DOG and BVA guideline no. 24b : Noninfectious uveitis posterior].

Authors: 
Journal:  Ophthalmologe       Date:  2017-12       Impact factor: 1.059

5.  Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.

Authors:  Cheng-bo Fang; De-xi Zhou; Shu-xiang Zhan; Yong He; Zhen Lin; Cheng Huang; Jun Li
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 6.  The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future.

Authors:  Martina Biggioggero; Chiara Crotti; Andrea Becciolini; Elisabetta Miserocchi; Ennio Giulio Favalli
Journal:  Biomed Res Int       Date:  2018-10-14       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.